What is AtriCure's EBITDA?

AtriCure (ATRC) reported EBITDA of $5.8M in Q1 2026.

How has AtriCure's EBITDA changed year-over-year?

AtriCure's EBITDA increased by 766.6% year-over-year, from -$870K to $5.8M.

What is the long-term trend for AtriCure's EBITDA?

Over 2 years (2022 to 2024), AtriCure's EBITDA has grown at a -17.1% compound annual growth rate (CAGR), from -$30.96M to -$21.28M.

What does EBITDA mean?

Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.

AtriCure ATRC EBITDA

Discontinued — last reported Q1 '26

EBITDA at other companies

ITG

Integer HoldingsITGR

$66.88M-15.8%

Avanos MedicalAVNS

$19.1M-4.0%

AbbottABT

——

Johnson & JohnsonJNJ

——

Boston ScientificBSX

——

MedtronicMDT

——

Other financials

Income statement

See full

Revenue$141.2M+14.3%

Gross profit$109.3M+18.0%

Operating income$526.0K+109%

Net income$108.0K+102%

EPS (diluted)$0.00+100%

Balance sheet

See full

Cash & equivalents$146.2M+46.3%

Total debt$76.2M-3.1%

Total equity$491.7M+8.2%

Total assets$644.0M+8.8%

Cash flow

See full

Operating cash flow-$4.0M+63.8%

CapEx$3.9M+76.6%

Free cash flow-$7.8M+40.6%

Valuation

See full

Market cap$1.43B-7.9%

Enterprise value$1.36B-11.2%

P/S2.6×-0.6×

Profitability

See full

Gross margin75.6%+0.8pp

Operating margin-5.1%-1.3pp

Net margin-5.6%-1.5pp

FCF margin9.7%—

Returns & leverage

See full

Return on equity-6.1%-1.3pp

Debt / equity0.2×0.0×

Current ratio4.3×+0.2×

Where this comes from

Calculated from AtriCure’s reported figures.

$526.0Kebit+

$5.3MDepreciation Depletion & Amortization

=$5.8M

The official record: AtriCure’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about AtriCure's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is AtriCure's EBITDA?: AtriCure (ATRC) reported EBITDA of $5.8M in Q1 2026.
How has AtriCure's EBITDA changed year-over-year?: AtriCure's EBITDA increased by 766.6% year-over-year, from -$870K to $5.8M.
What is the long-term trend for AtriCure's EBITDA?: Over 2 years (2022 to 2024), AtriCure's EBITDA has grown at a -17.1% compound annual growth rate (CAGR), from -$30.96M to -$21.28M.
What does EBITDA mean?: Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.